First human tests for new drug delivery method
NCT ID NCT07413133
Summary
This early-stage study aims to understand how the body absorbs and processes a new drug called ABBV-8736. It will compare giving the drug as a simple shot under the skin versus through an IV drip. The study involves 40 healthy adult volunteers to check how the drug moves through the body and to monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Acpru /Id# 280382
RECRUITINGGrayslake, Illinois, 60030, United States
-
CenExel ACT- Anaheim Clinical Trials /ID# 280481
RECRUITINGAnaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.